Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
JK-07 by Salubris Biotherapeutics for Diastolic Heart Failure (HFpEF): Likelihood of Approval
JK-07 is under clinical development by Salubris Biotherapeutics and currently in Phase II for Diastolic Heart Failure (HFpEF). According to...
Data Insights
JK-07 by Salubris Biotherapeutics for Systolic Heart Failure: Likelihood of Approval
JK-07 is under clinical development by Salubris Biotherapeutics and currently in Phase II for Systolic Heart Failure. According to GlobalData,...